International Journal of Molecular Sciences (May 2014)

Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer

  • Agnes V. Tallet,
  • David Azria,
  • Emilie Le Rhun,
  • Fabrice Barlesi,
  • Antoine F. Carpentier,
  • Antony Gonçalves,
  • Sophie Taillibert,
  • Frédéric Dhermain,
  • Jean-Philippe Spano,
  • Philippe Metellus

DOI
https://doi.org/10.3390/ijms15058138
Journal volume & issue
Vol. 15, no. 5
pp. 8138 – 8152

Abstract

Read online

Breast cancer is the second most common cause of brain metastases and deserves particular attention in relation to current prolonged survival of patients with metastatic disease. Advances in both systemic therapies and brain local treatments (surgery and stereotactic radiosurgery) have led to a reappraisal of brain metastases management. With respect to this, the literature review presented here was conducted in an attempt to collect medical evidence-based data on the use of whole-brain radiotherapy for the treatment of brain metastases from breast cancer. In addition, this study discusses here the potential differences in outcomes between patients with brain metastases from breast cancer and those with brain metastases from other primary malignancies and the potential implications within a treatment strategy.

Keywords